MedTrace Logo

Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management

NCT04774029 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-02-26

No results posted yet for this study

Summary

The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.

Conditions

  • Vertebral Compression
  • Vertebra Compression Fracture
  • Vertebral Fracture

Interventions

PROCEDURE

Basivertebral nerve block

Temporary intraosseous basivertebral nerve block using lidocaine

DRUG

Lidocaine induced basivertebral nerve block

Intraosseous lidocaine basivertebral nerve block

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Kenny Lien, MD · Northwell Health - Mather Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-10
Primary Completion
2020-04-01
Completion
2020-05-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774029 on ClinicalTrials.gov